Mettrum Health Corp. (TSXV:MT.V), a fully-integrated licensed producer of premium cannabis products, launched its much-anticipated line of Mettrum Cannabis Oils.
As quoted in the press release:

Mettrum Cannabis Oils will be priced at $90 for one 40 ml bottle, which contains the equivalent medicinal content of five grams of dried marijuana. Mettrum produces whole-flower cannabis extracts using state-of-the art supercritical fluid CO2 extraction technology. The process extracts the major cannabinoids (THC and CBD), as well as the minor cannabinoids, terpenes and flavonoids that contribute to the overall medicinal value of medical cannabis. The result of this process is a highly concentrated resin. This extract is then suspended in an oil to make it easier to administer orally.  Mettrum uses medium chain triglyceride oil (MCT) in our formulations.  MCT is naturally occurring and used widely in the food, pharmaceutical and natural products industry. It is highly stable, flavourless, odourless, and allows for increased absorption making it ideal to use in cannabis oils.
Today, Mettrum is launching three oils in the Red, Blue, and Yellow categories, in line with the Mettrum Spectrum™, a trademarked system that helps physicians and their patients select the cannabis strain or strains that are most appropriate for their particular medical need. The Mettrum Spectrum™ allows for the categorization of medical cannabis products based on different ratios of key medicinal cannabinoids: cannabidiol (CBD) and tetrahydrocannabinol (THC). The Blue and Yellow category oils are notably unique as they are derived from rare strains of cannabis with a high ratio of CBD to THC  ̶  making them a relevant treatment for an expanded population of prospective patients. In the coming weeks, additional products will be added to broaden the selection across the categories that make up the Mettrum Spectrum™.
The launch comes on the heels of the announcement that Mettrum received a license from Health Canada for the production of cannabis at its new 60,000-square-foot production facility in Bowmanville, Ontario.

Mettrum Health CEO, Michael Haines, stated:

As Canada’s second LP to receive a license to sell cannabis extracts, we’ve been working hard to deliver accessibly priced, premium oils for our clients. We are responding to the demand from patients and health care professionals alike for alternative consumption methods of medical cannabis.

Company is strategically building a diverse edibles portfolio with taste-forward and effects-driven products to cater to market and consumer needs

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced the launch of Wonder Wellness (“Wonder”) Gummies and availability in Illinois. The new low-dose edibles are enhanced with botanicals to complement the overall cannabis experience, and their simple packaging communicates desired effects so wellness-minded category newcomers can consume with confidence to add cannabis as a part of their daily lifestyles.

Keep reading... Show less

Reports Eighth Consecutive Quarter of Positive Adjusted EBITDA and Positive Adjusted EBITDA from Cannabis Business

 Aphria Inc. (” Aphria ,” ” we ,” or the ” Company “) (TSX: APHA) (NASDAQ: APHA), a leading global cannabis-lifestyle consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today reported its financial results for the third quarter and nine months ended February 28, 2021 . All amounts are expressed in Canadian dollars, unless otherwise noted and except for per gram, kilogram, kilogram equivalents, and per share amounts.

Keep reading... Show less

Thoughtful Brands, Inc. (CSE:TBI)(FWB:1WZ1)(OTCQB:PEMTF) (the “Company” or “Thoughtful Brands“), an eCommerce technology company that researches, develops, markets, and distributes natural health products through various brands in North America and Europe, announces that it intends to consolidate its issued and outstanding common shares (“Shares”) at a ratio of ten (10) pre-consolidated Shares to one (1) post-consolidation Share (the “Consolidation

The Company currently has 389,274,701 Shares issued and outstanding. Following the Consolidation there will be approximately 38,927,470 Shares issued and outstanding. No fractional Shares will be issued and any fractions of a Share will be rounded down to the nearest whole number of Shares. The exercise or conversion price and the number of Shares issuable under any of the Company’s outstanding convertible securities will be proportionately adjusted upon Consolidation.

Keep reading... Show less

In the evolving rush of mergers and acquisitions (M&A) in the Canadian cannabis market, Canopy Growth (NASDAQ:CGC,TSX:WEED) announced it will acquire The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) in a deal worth approximately C$435 million.

Meanwhile, a cannabis operator in the US confirmed this week that it will receive a financial boost from a partner to solidify its position in the burgeoning Pennsylvania state market.

Keep reading... Show less

The Board of Directors of Aphria Unanimously Recommends Shareholders Vote “For” the Arrangement

Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination

Keep reading... Show less